Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.54 CAD | -2.53% | -5.52% | -54.03% |
05-14 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.03% | 18.88M | |
+60.41% | 55.07B | |
-1.85% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+12.32% | 26.28B | |
-21.01% | 18.93B | |
+6.91% | 13.03B | |
+28.36% | 12.26B | |
+25.86% | 12.21B |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- RBC Cuts Price Target on Aptose Biosciences to $6 From $7, Maintains Outperform Rating, Speculative Risk Qualifier